A citation-based method for searching scientific literature

Balazs Halmos, Thomas Burke, Chrysostomos Kalyvas, Ralph Insinga, Kristel Vandormael, Andrew Frederickson, Bilal Piperdi. Cancers (Basel) 2020
Times Cited: 8







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.
James E Signorovitch, Vanja Sikirica, M Haim Erder, Jipan Xie, Mei Lu, Paul S Hodgkins, Keith A Betts, Eric Q Wu. Value Health 2012
179
37

Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison.
Balazs Halmos, Thomas Burke, Chrysostomos Kalyvas, Kristel Vandormael, Andrew Frederickson, Bilal Piperdi. Lung Cancer 2021
6
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
25

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
Fred R Hirsch, Abigail McElhinny, Dave Stanforth, James Ranger-Moore, Malinka Jansson, Karina Kulangara, William Richardson, Penny Towne, Debra Hanks, Bharathi Vennapusa,[...]. J Thorac Oncol 2017
855
25

Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study.
Michael Boyer, Mehmet A N Şendur, Delvys Rodríguez-Abreu, Keunchil Park, Dae Ho Lee, Irfan Çiçin, Perran Fulden Yumuk, Francisco J Orlandi, Ticiana A Leal, Olivier Molinier,[...]. J Clin Oncol 2021
65
25

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Luis Paz-Ares, Tudor-Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Zurawski, Juliana Menezes, Eduardo Richardet, Jaafar Bennouna, Enriqueta Felip, Oscar Juan-Vidal,[...]. Lancet Oncol 2021
329
25

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
25

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Shirish Gadgeel, Delvys Rodríguez-Abreu, Giovanna Speranza, Emilio Esteban, Enriqueta Felip, Manuel Dómine, Rina Hui, Maximilian J Hochmair, Philip Clingan, Steven F Powell,[...]. J Clin Oncol 2020
392
25

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Matthew D Hellmann, Luis Paz-Ares, Reyes Bernabe Caro, Bogdan Zurawski, Sang-We Kim, Enric Carcereny Costa, Keunchil Park, Aurelia Alexandru, Lorena Lupinacci, Emmanuel de la Mora Jimenez,[...]. N Engl J Med 2019
25

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
Patricia Guyot, A E Ades, Mario J N M Ouwens, Nicky J Welton. BMC Med Res Methodol 2012
996
25

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.
James E Signorovitch, Eric Q Wu, Andrew P Yu, Charles M Gerrits, Evan Kantor, Yanjun Bao, Shiraz R Gupta, Parvez M Mulani. Pharmacoeconomics 2010
162
25

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal.
David M Phillippo, Anthony E Ades, Sofia Dias, Stephen Palmer, Keith R Abrams, Nicky J Welton. Med Decis Making 2018
118
25

Precision-guided long-acting analgesia by Gel-immobilized bupivacaine-loaded microsphere.
Wenjing Zhang, Cong Ning, Weiguo Xu, Hanze Hu, Mingqiang Li, Guoqing Zhao, Jianxun Ding, Xuesi Chen. Theranostics 2018
33
12

Spatiotemporally Targeted Nanomedicine Overcomes Hypoxia-Induced Drug Resistance of Tumor Cells after Disrupting Neovasculature.
Jinjin Chen, Zhongyu Jiang, Weiguo Xu, Tianmeng Sun, Xiuli Zhuang, Jianxun Ding, Xuesi Chen. Nano Lett 2020
51
12

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
Herbert Hurwitz, Louis Fehrenbacher, William Novotny, Thomas Cartwright, John Hainsworth, William Heim, Jordan Berlin, Ari Baron, Susan Griffing, Eric Holmgren,[...]. N Engl J Med 2004
12

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap.
Wantong Song, Limei Shen, Ying Wang, Qi Liu, Tyler J Goodwin, Jingjing Li, Olekasandra Dorosheva, Tianzhou Liu, Rihe Liu, Leaf Huang. Nat Commun 2018
202
12

Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
Claire F Verschraegen, Guy Jerusalem, Edward F McClay, Nicholas Iannotti, Charles H Redfern, Jaafar Bennouna, Franklin L Chen, Karen Kelly, Janice Mehnert, John C Morris,[...]. J Immunother Cancer 2020
9
12

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Rolf Sauer, Torsten Liersch, Susanne Merkel, Rainer Fietkau, Werner Hohenberger, Clemens Hess, Heinz Becker, Hans-Rudolf Raab, Marie-Therese Villanueva, Helmut Witzigmann,[...]. J Clin Oncol 2012
12

Protein homodimer sequestration with small molecules: Focus on PD-L1.
Christian Bailly, Gérard Vergoten. Biochem Pharmacol 2020
14
12

Biointerface engineering nanoplatforms for cancer-targeted drug delivery.
Huaiyu Zhang, Shujun Dong, Zhongmin Li, Xiangru Feng, Weiguo Xu, Catrina Mae S Tulinao, Yang Jiang, Jianxun Ding. Asian J Pharm Sci 2020
29
12

Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
Martin R Weiser, Hak-Mien Quah, Jinru Shia, José G Guillem, Philip B Paty, Larissa K Temple, Karyn A Goodman, Bruce D Minsky, W Douglas Wong. Ann Surg 2009
161
12

Polymer-Mediated Penetration-Independent Cancer Therapy.
Jianxun Ding, Xiangru Feng, Zhongyu Jiang, Weiguo Xu, Hui Guo, Xiuli Zhuang, Xuesi Chen. Biomacromolecules 2019
26
12


Polylactide-Cholesterol Stereocomplex Micelle Encapsulating Chemotherapeutic Agent for Improved Antitumor Efficacy and Safety.
Jixue Wang, Weiguo Xu, Shengxian Li, Heping Qiu, Zhibo Li, Chunxi Wang, Xiaoqing Wang, Jianxun Ding. J Biomed Nanotechnol 2018
31
12

Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.
Xian-De Liu, Anh Hoang, Lijun Zhou, Sarathi Kalra, Alper Yetil, Mianen Sun, Zhiyong Ding, Xuesong Zhang, Shanshan Bai, Peter German,[...]. Cancer Immunol Res 2015
121
12

Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report.
Yoshihisa Tokumaru, Nobuhisa Matsuhashi, Takao Takahashi, Toshiyuki Tanahashi, Satoshi Matsui, Hisashi Imai, Yoshihiro Tanaka, Kazuya Yamaguchi, Kazuhiro Yoshida. Mol Clin Oncol 2019
2
50

Chirality-mediated polypeptide micelles for regulated drug delivery.
Jianxun Ding, Chen Li, Ying Zhang, Weiguo Xu, Jincheng Wang, Xuesi Chen. Acta Biomater 2015
35
12

Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review.
Maria Røed Skårderud, Anne Polk, Kirsten Kjeldgaard Vistisen, Finn Ole Larsen, Dorte Lisbet Nielsen. Cancer Treat Rev 2018
31
12

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors-2020 Update.
Gerhard Jung, Daniel Benítez-Ribas, Ariadna Sánchez, Francesc Balaguer. J Clin Med 2020
13
12

Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity.
Scott M Wilhelm, Jacques Dumas, Lila Adnane, Mark Lynch, Christopher A Carter, Gunnar Schütz, Karl-Heinz Thierauch, Dieter Zopf. Int J Cancer 2011
833
12

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.
Sandip Pravin Patel, Razelle Kurzrock. Mol Cancer Ther 2015
12

Structural Basis for the Regulation of PPARγ Activity by Imatinib.
Jun Young Jang, Hyun-Jung Kim, Byung Woo Han. Molecules 2019
8
12

Synergistically Enhanced Mucoadhesive and Penetrable Polypeptide Nanogel for Efficient Drug Delivery to Orthotopic Bladder Cancer.
Hui Guo, Faping Li, Heping Qiu, Weiguo Xu, Pengqiang Li, Yuchuan Hou, Jianxun Ding, Xuesi Chen. Research (Wash D C) 2020
20
12

Laden Nanofiber Capsules for Local Malignancy Chemotherapy.
Yifu Sun, Hongli Shan, Jixue Wang, Xiaoqing Wang, Xiaoyu Yang, Jianxun Ding. J Biomed Nanotechnol 2019
7
14

Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2.
Krzysztof M Zak, Przemyslaw Grudnik, Katarzyna Magiera, Alexander Dömling, Grzegorz Dubin, Tad A Holak. Structure 2017
158
12

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.
Sylvia Adams, Lina Kozhaya, Frank Martiniuk, Tze-Chiang Meng, Luis Chiriboga, Leonard Liebes, Tsivia Hochman, Nicholas Shuman, Deborah Axelrod, James Speyer,[...]. Clin Cancer Res 2012
145
12

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
Jiali Li, Wenru Song, Debra K Czerwinski, Bindu Varghese, Satoshi Uematsu, Shizuo Akira, Arthur M Krieg, Ronald Levy. J Immunol 2007
97
12

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
Robert H I Andtbacka, Merrick Ross, Igor Puzanov, Mohammed Milhem, Frances Collichio, Keith A Delman, Thomas Amatruda, Jonathan S Zager, Lee Cranmer, Eddy Hsueh,[...]. Ann Surg Oncol 2016
177
12

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.
Geertje J D van Mierlo, Annemieke Th den Boer, Jan Paul Medema, Ellen I H van der Voort, Marieke F Fransen, Rienk Offringa, Cornelis J M Melief, Rene E M Toes. Proc Natl Acad Sci U S A 2002
183
12

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.
Shailender Bhatia, Natalie V Longino, Natalie J Miller, Rima Kulikauskas, Jayasri G Iyer, Dafina Ibrani, Astrid Blom, David R Byrd, Upendra Parvathaneni, Christopher G Twitty,[...]. Clin Cancer Res 2020
41
12

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.
M E Rodríguez-Ruiz, J L Perez-Gracia, I Rodríguez, C Alfaro, C Oñate, G Pérez, I Gil-Bazo, A Benito, S Inogés, A López-Diaz de Cerio,[...]. Ann Oncol 2018
76
12

CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response.
James E Wooldridge, George J Weiner. Curr Opin Oncol 2003
33
12

Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms.
Iñaki Etxeberria, Irene Olivera, Elixabet Bolaños, Asunta Cirella, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero. Cell Mol Immunol 2020
6
16



IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Connie Jackaman, Christine S Bundell, Beverley F Kinnear, Alison M Smith, Pierre Filion, Deborah van Hagen, Bruce W S Robinson, Delia J Nelson. J Immunol 2003
154
12

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
Claire Vanpouille-Box, Amandine Alard, Molykutty J Aryankalayil, Yasmeen Sarfraz, Julie M Diamond, Robert J Schneider, Giorgio Inghirami, C Norman Coleman, Silvia C Formenti, Sandra Demaria. Nat Commun 2017
842
12

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Barbara Burtness, Kevin J Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland,[...]. Lancet 2019
996
12

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.
Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Virna Cortez-Retamozo, Christopher Garris, Ferdinando Pucci, Takahiro Yamazaki, Vichnou Poirier-Colame, Andita Newton, Younes Redouane,[...]. Immunity 2016
542
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.